Sort
21,281 grants matching “influenza”
IN VIVO EFFECTS OF BACTERIAL SUPERANTIGENS
$346,000Trudeau Institute, Inc. · R01 · FY2004 · AI
A Resource Center for Tetrahymena Thermophila
$345,971Theodore G Clark · Cornell University · P40 · FY2017 · OD
CD4 T cell protection and pathology in the lung
$345,939Trudeau Institute, Inc. · P01 · FY2004 · HL
Calcium and Cytotoxic T Lymphocytes
$345,938University Of Colorado Denver · R01 · FY2004 · AI
Developing Myxovirus Inhibitors with Expanded Pathogen Target Range
$345,739Richard K. Plemper · Georgia State University · R01 · FY2013 · AI
Rhinovirus and COPD exacerbations
$345,680Marc B Hershenson · University Of Michigan At Ann Arbor · R01 · FY2007 · HL
Ebola VP35 Interferon-Antagonist: Mechanism and Signif
$345,672Christopher F Basler · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · AI
Mapping Adeno-associated Virus Capsid Structural and Dynamic Transitions
$345,648Brian P Bothner · Montana State University - Bozeman · R01 · FY2011 · AI
T cell responses of nasal mucosa and lymphoid tissues
$345,618Trudeau Institute, Inc. · P01 · FY2004 · HL
University of Washington Vaccine and Treatment Evaluation Unit
$345,560Anna Wald · University Of Washington · UM1 · FY2022 · AI
Genetics /Biology of M. catarrhalis LOS in Otitis Media
$345,548State University Of New York At Buffalo · R01 · FY2002 · DC
Alternative approaches for NALT-based immunity to respiratory pathogens
$345,486Prosper N Boyaka · Ohio State University · R01 · FY2013 · AI
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
$345,444Andras Fiser · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Microbiology and Biospecimen Core
$345,443Yury A Bochkov · University Of Wisconsin-Madison · P01 · FY2017 · HL
METHODS FOR EVALUATING VACCINE EFFICACY
$345,422Emory University · R01 · FY2001 · AI
Rhinovirus and COPD exacerbations
$345,389Marc B Hershenson · University Of Michigan At Ann Arbor · R01 · FY2008 · HL
New DC-targeting Vaccine Constructs and Antibody Reagents
$345,379Gerard Zurawski · Baylor Research Institute · U19 · FY2012 · AI
Expression, Biochemistry and Immune Reagent Core
$345,363Mark T Heise · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
Clinical subjects and recruitment
$345,355Albert C Shaw · Yale University · U19 · FY2022 · AI
Systems investigation of vaccine responses in B cell depleted autoimmune patients
$345,355David A. Hafler · Yale University · U19 · FY2022 · AI
Systems investigation of vaccine responses in aging and frailty
$345,354Albert C Shaw · Yale University · U19 · FY2022 · AI
Inflammatory dysregulation of vaccine responses in sickle cell disease
$345,353Ruth R Montgomery · Yale University · U19 · FY2022 · AI
TRANSLATIONAL CONTROL IN INFLUENZA VIRUS INFECTED CELLS
$345,270University Of Washington · R01 · FY2002 · AI
CHEMOKINE ENHANCED IMMUNE THERAPY OF LYMPHOMA
$345,257University Of Rochester · R01 · FY2000 · CA
T-Cells in Lung Inflammation
$345,150Peter N Kao · Stanford University · R01 · FY2011 · AI